AllianceBernstein
BIOA

AllianceBernstein’s BioAge Labs BIOA Stock Holding History

AllianceBernstein’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Buy
+29,000
New +$558K ﹤0.01% 2770
2024
Q4 		– Sell
-994,315
Closed -$20.7M – 3253
2024
Q3 		$20.7M Buy
+994,315
New +$19.9M 0.01% 902

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AllianceBernstein's BIOA Position: Q1 2026 in Review

AllianceBernstein opened a new position in BioAge Labs (BIOA) in Q1 2026: 29,000 shares worth $384K. The stake represents ﹤0.01% of the portfolio and ranks #2770 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in BIOA as recently as Q3 2024.

AllianceBernstein first reported a position in BIOA in Q3 2024 and has held it in 2 quarters since. The position peaked at $20.7M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • AllianceBernstein held 29,000 shares of BioAge Labs worth $384K as of Q1 2026.
  • BioAge Labs was a new AllianceBernstein position in Q1 2026.
  • BioAge Labs made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2770 holding.
  • AllianceBernstein first reported a position in BioAge Labs in Q3 2024 and has held it in 2 quarters since.
  • AllianceBernstein's BioAge Labs position peaked at $20.7M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.